Pharmaceutical Security Production Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Pharmaceutical Security Production Act
This bill establishes the Commission on Strengthening the Domestic Pharmaceutical Supply Chain.
The commission must assess the security and vulnerabilities of the domestic pharmaceutical supply chain in the United States and recommend improvements, including by developing metrics for domestic manufacturing programs, proposing solutions to strengthen the domestic manufacturing workforce, and evaluating ways to support a financial market for domestically manufactured products.
The commission terminates four years after the bill is enacted.
Referred to the Subcommittee on Health.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 4449: Pharmaceutical Security Production Act. 118th Congress. Open America. https://openamerica.io/bill/118-HR-4449/
"H.R. 4449: Pharmaceutical Security Production Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-4449/.
H.R. 4449, 118th Cong. (2026), https://openamerica.io/bill/118-HR-4449/.
[H.R. 4449: Pharmaceutical Security Production Act](https://openamerica.io/bill/118-HR-4449/)